Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The primary objective of this study is to assess the safety and efficacy of ABT-510 in subjects with advanced renal cell carcinoma.
Epistemonikos ID: 05e63a9f43bc2486890e11f35111adcc30d4f7ff
First added on: Jul 10, 2018